19 results found.

Deep Venous Thrombosis, or Pulmonary Embolism Clinical Trial using LMWH

Leiden University Medical Center - Recruiting 18 years or older.
- Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation: Determining the Balance Between Benefits and Risks.
LMWH

Deep Venous Thrombosis, or Pulmonary Embolism Clinical Trial using LMWH

Leiden University Medical Center - Recruiting 18 years or older.
- Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy: Determining the Balance Between Benefits and Risks.
LMWH

Atrial Fibrillation or Pulmonary Embolism, Need of Long Term Oral Clinical Trial using Rivaroxaban or Marcumar

RWTH Aachen University - Recruiting 18 years or older.
- Influence of Rivaroxaban Compared to Vitamin K Antagonist Treatment Upon Development of Cardiovascular Calcification in Patients With Atrial Fibrillation and/ or Pulmonary Embolism.
Rivaroxaban or Marcumar

Subsegmental (Single or Multiple) Pulmonary Embolism Clinical Trial

Ottawa Hospital Research Institute - Recruiting 18 years or older.
- A Multicenter Prospective Cohort Management Study to Evaluate the Safety of Withholding Anticoagulation in Patients With Subsegmental PE Who Have a Negative Serial Bilateral Lower Extremity Ultrasound.

Recent Stroke, Pulmonary Embolism, or Patent Foramen Ovale Clinical Trial

University Hospital, Brest - Recruiting 18 years or older.
- Is There a Link Between Venous Thromboembolism and Stroke in Patient With Patent Foramen Ovale ? Research for Stroke in Hospitalized Patients With Pulmonary Embolism..

HTPPE, or Idiopathic Pulmonary Embolism Clinical Trial using HTPPE

University Hospital, Brest - Recruiting 18 years or older.
- Frequency and Risk Factors of the Lung High Blood Pressure Post-embolique in the Fall of a First Episode of Idiopathic Pulmonary Embolism. Study ' PADIS HTP '.
HTPPE

Pulmonary Embolism Clinical Trial using Rivaroxoban (Xarelto, Bay59-7939); Acenocoumarol

Bayer - Recruiting 2 years to 89 years.
- A Proposed Pharmacoepidemiological Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice in the Netherlands..
Rivaroxoban (Xarelto, Bay59-7939); Acenocoumarol

Pulmonary Embolism Clinical Trial using Rivaroxaban (Xarelto, Bay59-7939); Phenprocoumon

Bayer - Recruiting 2 years to 89 years.
- A Proposed Pharmacoepidemiological Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice in Germany.
Rivaroxaban (Xarelto, Bay59-7939); Phenprocoumon

Pulmonary Embolism Clinical Trial using VenaTech Convertible Vena Cava Filter; Vena Cava Filter Conversion

B. Braun Interventional Systems, Inc - Recruiting 18 years or older.
- VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial.
VenaTech Convertible Vena Cava Filter; Vena Cava Filter Conversion

Deep Vein Thrombosis (DVT), or Pulmonary Embolism Clinical Trial using Bemiparin

Hawler Medical University - Recruiting 25 years to 90 years.
- Bemiparin as a Thromboprophylaxis After Benign Gynaecological Surgeries:A Randomized Clinical Trial.
Bemiparin

Pulmonary Embolism Clinical Trial using Catheter directed debulking of Pulmonary Embolus

Stanford University - Recruiting 18 years or older.
- Pulmonary Embolism Response to Fragmentation, Embolectomy, & Catheter Thrombolysis: The PERFECT Registry.
Catheter directed debulking of Pulmonary Embolus

Chronic Obstructive Pulmonary Disease, or Patients Hospitalized f Clinical Trial using PEP

University Hospital, Brest - Recruiting 18 years or older.
- Frequency of Diagnostic Symptomatic Pulmonary Embolism's in Patients Hospitalized for Clinical Exacerbation of Chronic Obstructive Pulmonary Disease (COPD).
PEP

Pulmonary Embolism Clinical Trial using 25 mg Actilyse ( Boehringer Ingelheim, Germany) infusion in 6 hours

Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital - Recruiting 18 years or older.
- Low Dose Prolonged Infusion of Tissue Type Plasminogen Activator Therapy in Massive Pulmonary Embolism: AYKAN Trial.
25 mg Actilyse ( Boehringer Ingelheim, Germany) infusion in 6 hours

Deep Vein Thrombosis, or Pulmonary Embolism Clinical Trial using Rosuvastatin

Leiden University Medical Center - Recruiting 18 years or older.
- Prospective Randomized Controlled, Open Label, Clinical Trial to Study if Rosuvastatin Use Improves the Coagulation Profile in Patients With Venous Thrombosis.
Rosuvastatin

Venous Thromboembolism, or Pulmonary Embolism Clinical Trial using dalteparin injection

University of Rochester - Recruiting 18 years or older.
- A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients.
dalteparin injection

Pulmonary Embolism Clinical Trial

Azienda Ospedaliero-Universitaria Careggi - Recruiting 18 years or older.
- Prognostic Value of Plasma Lactate Levels Among Patients With Acute Pulmonary Embolism: the Thrombo-Embolism Lactate Outcome Study.

Medical Patient, or Thrombocytopenia Clinical Trial using Fondaparinux

G. d'Annunzio University - Recruiting 18 years or older.
- Thromboprophylaxis With Fondaparinux of Deep Vein Thrombosis and Pulmonary Embolism in the Acutely-ill Medical Inpatients With Thrombocytopenia.
Fondaparinux

Venous Thrombosis, or Pulmonary Embolism Clinical Trial using Enoxaparin

Monash Medical Centre - Recruiting 18 years or older.
- Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis (TWISTER).
Enoxaparin

Venous Thrombosis, Pulmonary Embolism, or Atrial Fibrillation Clinical Trial using Warfarin

Hadassah Medical Organization - Recruiting 18 years or older.
- Warfarin Induction Regimen Based Upon CYP2C9, VKORC1 Factor VII Genotyping, PMR and INR Monitoring, as Compared to the Conventional Regimen: a Prospective Controlled Study.
Warfarin